Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilizationF Bertolini, A Lanza, F Peccatori, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1986
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancerG Robustelli della Cuna, P Zanon, L Pavesi, et al.
Anticancer Research|March 1, 1995
Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancerL Pavesi, P Preti, G Da Prada, et al.
International Archives of Occupational and Environmental Health|August 14, 1999
Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: comparison with sister chromatid exchange frequencyA Lanza, F S Robustelli della Cuna, C Zibera, et al.
Minerva Medica|May 31, 1984
[Chemotherapy, immunotherapy and supportive therapy in cerebral metastases]G Robustelli della Cuna, P Preti, L Pavesi, et al.
Journal of Neurosurgical Sciences|January 1, 1985
Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumorsR Knerich, G Robustelli della Cuna, G Butti, et al.
Anticancer Research|September 1, 1992
Proliferative effect of dexamethasone on a human glioblastoma cell line (HU 197) is mediated by glucocorticoid receptorsC Zibera, N Gibelli, G Butti, et al.
Minerva Medica|May 19, 1984
[Steroid receptors in brain tumors]G Robustelli della Cuna, C Zibera, D Fortunati, et al.
Anticancer Research|November 1, 1992
Effect of natural beta-interferon on estrogen receptor mRNA of breast cancer cellsG Sica, C Angelucci, F Iacopino, et al.
Anticancer Research|July 1, 1996
CG5/Dx human breast cancer cell line: characterization of a new doxorubicin-resistant variantN Gibelli, C Zibera, A Asti, et al.
Pageof 19